(CPXJ) iShares VII Public - Ratings and Ratios
Stocks, Asian, Companies, Technology, Finance
Description: CPXJ iShares VII Public
The iShares Core MSCI Pacific ex Japan UCITS ETF (CPXJ) is an exchange-traded fund that tracks the Morningstar Developed Asia Pacific ex Japan Total Market Index. It is designed to provide investors with exposure to a broad range of equities in the Pacific region, excluding Japan.
From a geographical perspective, the fund is likely to have a significant allocation to countries such as Australia, China, Hong Kong, and Singapore, which are major economies in the region. The funds underlying index is a market-capitalization-weighted index, meaning that the largest companies in the region will have a greater representation in the fund.
In terms of key performance indicators (KPIs), some relevant metrics to evaluate the funds performance include its tracking error, expense ratio, and dividend yield. A low tracking error indicates that the fund is effectively replicating the performance of its underlying index. The expense ratio is a measure of the funds operating costs, and a lower ratio is generally more desirable. The dividend yield can provide insight into the funds income-generating potential.
Given the funds AUM of €2876.42M, it appears to have a significant presence in the market, which can contribute to liquidity and potentially lower trading costs. To further evaluate the funds attractiveness, investors may also consider its historical returns, volatility, and Sharpe ratio relative to its peers and benchmark index.
To make an informed investment decision, it is essential to assess the funds performance in the context of the overall market environment and the investors individual goals and risk tolerance. This may involve analyzing the funds sector allocation, stock holdings, and other relevant characteristics to determine its potential fit within a broader investment portfolio.
Additional Sources for CPXJ ETF
CPXJ ETF Overview
Market Cap in USD | 3,837m |
Category | Pacific ex-Japan Equity |
TER | 0.20% |
IPO / Inception | 2010-01-12 |
CPXJ ETF Ratings
Growth Rating | 48.8 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -4.68 |
Analysts | - |
Fair Price Momentum | 166.54 EUR |
Fair Price DCF | - |
CPXJ Dividends
Currently no dividends paidCPXJ Growth Ratios
Growth Correlation 3m | 73.5% |
Growth Correlation 12m | 23.9% |
Growth Correlation 5y | 70.6% |
CAGR 5y | 7.95% |
CAGR/Max DD 5y | 0.40 |
Sharpe Ratio 12m | 0.84 |
Alpha | -0.26 |
Beta | 0.730 |
Volatility | 11.86% |
Current Volume | 0.2k |
Average Volume 20d | 0.5k |
Stop Loss | 175.8 (-3%) |
As of July 18, 2025, the stock is trading at EUR 181.26 with a total of 224 shares traded.
Over the past week, the price has changed by +0.97%, over one month by +1.71%, over three months by +13.63% and over the past year by +9.05%.
Partly, yes. Based on ValueRay´s Analyses, iShares VII Public (AS:CPXJ) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.75 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CPXJ is around 166.54 EUR . This means that CPXJ is currently overvalued and has a potential downside of -8.12%.
iShares VII Public has no consensus analysts rating.
According to our own proprietary Forecast Model, CPXJ iShares VII Public will be worth about 190.3 in July 2026. The stock is currently trading at 181.26. This means that the stock has a potential upside of +5%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 190.3 | 5% |